LoginSignup
Coloplast logo

Coloplast

Stock
Stock
ISIN: DK0060448595
Ticker: COLO B
DK0060448595
COLO B

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Coloplast has so far distributed $3.129 in 2024. The next dividend will be paid on 15.05.2025

$0.983

CHART BY

Frequently asked questions

What is Coloplast's market capitalization?

The market capitalization of Coloplast is $25.12B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Coloplast's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Coloplast is 35.49. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Coloplast?

Coloplast's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.164. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Coloplast's stock?

Currently, 27 analysts cover Coloplast's stock, with a consensus target price of $128.74. Analyst ratings provide insights into the stock's expected performance.

What is Coloplast's revenue over the trailing twelve months?

Over the trailing twelve months, Coloplast reported a revenue of $3.78B.

What is the EBITDA for Coloplast?

Coloplast's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.22B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Coloplast?

Coloplast has a free cash flow of $223.73M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Coloplast have, and what sector and industry does it belong to?

Coloplast employs approximately 16,639 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Coloplast's shares?

The free float of Coloplast is 142.07M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$25.12B
EPS (TTM) 
$3.164
Free Float 
142.07M
P/E ratio (TTM) 
35.49
Revenue (TTM) 
$3.78B
EBITDA (TTM) 
$1.22B
Free Cashflow (TTM) 
$223.73M

Pricing

1D span
$109.46$114.53
52W span
$108.46$143.25

Analyst Ratings

The price target is $128.74 and the stock is covered by 27 analysts.

Buy

8

Hold

15

Sell

4

Information

Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

Employees
16,639
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
DK0060448595
Primary Ticker
COLO B

Knockouts

Join the conversation
Sign upLogin